MEDITE CANCER DIAGNOSTICS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
MEDITE CANCER DIAGNOSTICS, INC. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $5.55 million as of 2015-12-31, per its 10-K filed 2016-04-12.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Liability Assumed, Liability
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2016-04-12
- 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $5.55M.
- 2015-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $3.34M.
- 2015-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $3.34M.
- 2015-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $3.34M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2015-12-31 | $5.55M 10-K · filed 2016-04-12 |
| 2015-09-30 | $3.34M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $3.34M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $3.34M 10-Q · filed 2015-05-22 |
| 2014-12-31 | $3.34M 10-K · filed 2015-05-11 |
| 2014-09-30 | $3.03M 10-Q · filed 2014-11-20 |
| 2014-06-30 | $3.03M 10-Q · filed 2015-02-26 |